Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061626) titled 'Effectiveness of Health Information and Visualization for Workers' on June 3.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Ezaki Glico Co., Ltd
Condition:
Condition - Metabolic syndrome and healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To examine the impact of a series of health awareness activities including health status assessment, information provision, and participatory events on worker's health, awareness, and behavior.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Education, Health score,Interactive event
Eligibility:
Age-lower limit - 30
years-old
=
Gender - Male and Female
Key inclusion criteria - 1.Age 30 to 64 at consent, including healthy men and women and those meeting criteria for metabolic syndrome or specified health guidance
2. Able to understand the study purpose and content, voluntarily agree, and provide written informed consent.
Key exclusion criteria - 1. Severe allergy risk to specified foods (almond, milk)
2. Pregnant, possibly pregnant, or breastfeeding
3. Implanted or life-support medical devices
4. Unable to attend workplace (serious illness, on leave, remote work only, or medically restricted)
5. Did not undergo 2025 health checkup
6. Not enrolled in Glico Health Insurance (applies only to Glico employees).
Target Size - 600
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 02 Month 24 Day
Date of IRB - 2026 Year 02 Month 24 Day
Anticipated trial start date - 2026 Year 06 Month 05 Day
Last follow-up date - 2027 Year 08 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070509
Disclaimer: Curated by HT Syndication.
